Mechanisms of a clonidine-induced decrease in portal pressure in normal and cirrhotic conscious rats.

Area of Science:

• Pharmacology
• Hepatology
• Cardiovascular Physiology

Background:

• Cirrhosis-induced portal hypertension is a serious complication.
• Splanchnic circulation plays a key role in portal hypertension.
• Sympathetic nervous system activity is altered in liver disease.

Purpose of the Study:

• To investigate the effects of clonidine on portal pressure and splanchnic blood flow in a rat model of cirrhosis.
• To explore the role of sympathetic regulation in cirrhotic portal hypertension.

Main Methods:

• Conscious rats with bile duct ligation-induced cirrhosis and sham-operated controls were used.
• Intravenous administration of clonidine (20 µg/kg) or placebo.
• Measurement of portal pressure, systemic hemodynamics, and portal tributary blood flow (radioactive microsphere method).
• Assay of plasma noradrenaline concentration.

Main Results:

• Clonidine significantly reduced portal pressure in both cirrhotic and sham-operated rats.
• In cirrhotic rats, clonidine increased portal tributary vascular resistance and decreased portal tributary blood flow.
• In sham-operated rats, clonidine decreased hepatic portal vascular resistance without altering portal tributary blood flow.
• Clonidine significantly decreased plasma noradrenaline levels in both groups.

Conclusions:

• Clonidine effectively reduces portal pressure in cirrhotic rats.
• The mechanism of action differs between cirrhotic and healthy rats, involving altered splanchnic vascular resistance.
• Reduced plasma noradrenaline suggests a role for sympathetic activity modulation.
• These findings indicate impaired sympathetic regulation of splanchnic circulation in cirrhosis.